| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8791053 | American Journal of Ophthalmology Case Reports | 2018 | 5 Pages |
Abstract
CML patients can have features similar to VKH even during stable hematological phase and may be possibly associated with the use of tyrosine kinase inhibitors. Hence it is important not to misdiagnose and treat such patients with long term immunomodulators.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Saurabh Mistry, S. Sudharshan, Suganeswari Ganesan, Ashraf Banu Akbar, Jyotirmay Biswas,